Сравнение

Carbetocin vs. Ganirelix

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

37025-55-1

123246-29-7

Молекулярная масса

нет данных

1570.3 g/mol

Период полувыведения

0.67 h

нет данных

Последовательность

нет данных

Механизм действия

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Carbetocin	Ganirelix
Германия	Рецептурный	Рецептурный
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Carbetocin and Ganirelix?: Carbetocin is classified as "Исследования (прочее)", while Ganirelix is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Ganirelix?: The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Ganirelix. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Ganirelix in Germany and the United States?: Германия: Carbetocin — Рецептурный, Ganirelix — Рецептурный. США: Carbetocin — Не одобрено, Ganirelix — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Ganirelix

Германия

Рецептурный

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Carbetocin and Ganirelix?

Carbetocin is classified as "Исследования (прочее)", while Ganirelix is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Ganirelix?

The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Ganirelix. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Ganirelix in Germany and the United States?

Германия: Carbetocin — Рецептурный, Ganirelix — Рецептурный. США: Carbetocin — Не одобрено, Ganirelix — Рецептурный. These are factual summaries with source and review date on the individual pages.